Rabies virus vaccines: is there a need for a pan-lyssavirus vaccine?

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Vaccine

• Publication date

  2012-12-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2012.10.015PMID 23084854
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ikoma Lyssavirus, Highly Divergent Novel Lyssavirus in an African Civet

  2012cited by this paper
• Chimeric rabies viruses for trans-species comparison of lyssavirus glycoprotein ectodomain functions in virus replication and pathogenesis.

  2012cited by this paper
• Passive immunity in the prevention of rabies.

  2012cited by this paper
• Complete Genome Sequence of Ikoma Lyssavirus

  2012cited by this paper
• Bats and lyssaviruses.

  2011cited by this paper
• Human rabies encephalitis prevention and treatment: progress since Pasteur's discovery.

  2011cited by this paper
• Novel Lyssavirus in Natterer’s Bat, Germany

  2011cited by this paper
• Phylogeny of European bat Lyssavirus 1 in Eptesicus isabellinus bats, Spain.

  2011cited by this paper
• Phylogeny of European Bat Lyssavirus 1 in Eptesicus isabellinus Bats, Spain

  2011cited by this paper
• The Feasibility of Canine Rabies Elimination in Africa: Dispelling Doubts with Data

  2010cited by this paper
• Shimoni bat virus, a new representative of the Lyssavirus genus.

  2010cited by this paper
• Quantifying Antigenic Relationships among the Lyssaviruses

  2010cited by this paper
• First encounter of European bat lyssavirus type 2 (EBLV-2) in a bat in Finland

  2010cited by this paper
• Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus

  2009cited by this paper
• A fatal case of bat lyssavirus infection in Primorye Territory of the Russian Far East.

  2009cited by this paper
• Vaccines for Biodefense and Emerging and Neglected Diseases

  2009cited by this paper
• Emerging Technologies for the Detection of Rabies Virus: Challenges and Hopes in the 21st Century

  2009cited by this paper
• European Bat Lyssavirus Transmission among Cats, Europe

  2009cited by this paper
• Antibodies against Lagos Bat Virus in Megachiroptera from West Africa

  2008cited by this paper
• Can rabies be eradicated?

  2008cited by this paper
• Fatal case of human rabies (Duvenhage virus) from a bat in Kenya: The Netherlands, December 2007.

  2008cited by this paper
• Phylogeny of Lagos bat virus: challenges for lyssavirus taxonomy.

  2008cited by this paper
• Epidemiology and pathogenicity of African bat lyssaviruses.

  2008cited by this paper
• Complete genomes of Aravan, Khujand, Irkut and West Caucasian bat viruses, with special attention to the polymerase gene and non-coding regions.

  2008cited by this paper
• A reliable diagnosis of human rabies based on analysis of skin biopsy specimens.

  2008cited by this paper
• The Glycoprotein and the Matrix Protein of Rabies Virus Affect Pathogenicity by Regulating Viral Replication and Facilitating Cell-to-Cell Spread

  2007cited by this paper
• Rabies Encephalitis in Malaria-Endemic Area, Malawi, Africa

  2007cited by this paper
• Cross-protective and cross-reactive immune responses to recombinant vaccinia viruses expressing full-length lyssavirus glycoprotein genes

  2007cited by this paper
• Comparative analysis of the full genome sequence of European bat lyssavirus type 1 and type 2 with other lyssaviruses and evidence for a conserved transcription termination and polyadenylation motif in the G-L 3' non-translated region.

  2007cited by this paper
• Natural and experimental infection of sheep with European bat lyssavirus type-1 of Danish bat origin.

  2006cited by this paper
• Fatal Human Infection with Rabies-related Duvenhage Virus, South Africa

  2006cited by this paper
• A highly attenuated rabies virus HEP-Flury strain reverts to virulent by single amino acid substitution to arginine at position 333 in glycoprotein.

  2006cited by this paper
• Rabies remains a 'neglected disease'.

  2005cited by this paper
• Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses.

  2005cited by this paper
• Efficacy of rabies biologics against new lyssaviruses from Eurasia.

  2005cited by this paper
• Re-evaluating the burden of rabies in Africa and Asia.

  2005cited by this paper
• Vaccines for lyssaviruses other than rabies

  2005cited by this paper
• Spill-over of European bat lyssavirus type 1 into a stone marten (Martes foina) in Germany.

  2004cited by this paper
• The challenge of new and emerging lyssaviruses

  2004cited by this paper
• Mapping the Antigenic and Genetic Evolution of Influenza Virus

  2004cited by this paper
• Case report: Isolation of a European bat lyssavirus type 2a from a fatal human case of rabies encephalitis

  2003cited by this paper
• Novel Lyssaviruses Isolated from Bats in Russia

  2003cited by this paper
• Sequence analysis of an isolate from a fatal human infection of Australian bat lyssavirus.

  2002cited by this paper
• Overexpression of the Rabies Virus Glycoprotein Results in Enhancement of Apoptosis and Antiviral Immune Response

  2002cited by this paper
• Evidence of Two Lyssavirus Phylogroups with Distinct Pathogenicity and Immunogenicity

  2001cited by this paper
• Molecular epidemiology

  2001cited by this paper
• Australian bat lyssavirus infection: a second human case, with a long incubation period

  2000cited by this paper
• Potential exposure to Australian bat lyssavirus, Queensland, 1996-1999.

  2000cited by this paper
• Lyssavirus glycoproteins expressing immunologically potent foreign B cell and cytotoxic T lymphocyte epitopes as prototypes for multivalent vaccines.

  1999cited by this paper
• Deduced structural model for animal rhabdovirus glycoproteins.

  1999cited by this paper
• Human infection due to Ebola virus, subtype Côte d'Ivoire: clinical and biologic presentation.

  1999cited by this paper
• Chimeric Lyssavirus Glycoproteins with Increased Immunological Potential

  1999cited by this paper
• A human case of encephalitis due to a lyssavirus recently identified in fruit bats

  1996cited by this paper
• Mokola virus glycoprotein and chimeric proteins can replace rabies virus glycoprotein in the rescue of infectious defective rabies virus particles

  1995cited by this paper
• The rabies virus genome: an overview.

  1993cited by this paper
• Rabies virus glycoprotein is a trimer

  1992cited by this paper
• Antigenicity of rabies virus glycoprotein

  1991cited by this paper
• Rabies-related Yuli virus; identification with a panel of monoclonal antibodies.

  1989cited by this paper
• Rabies-related Yuli virus; identification with a panel of monoclonal antibodies.

  1989cited by this paper
• Rabies-Related Viruses

  1988cited by this paper
• Efficacy of rabies vaccines against Duvenhage virus isolated from European house bats (Eptesicus serotinus), classic rabies and rabies-related viruses.

  1988cited by this paper
• Human rabies of bat origin in Europe.

  1986cited by this paper
• Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies.

  1983cited by this paper
• Giulio Alfredo Maccacaro.

  1977cited by this paper
• Laboratory techniques in rabies: the fluorescent antibody test.

  1973cited by this paper
• A fatal human infection with Mokola virus.

  1972cited by this paper
• Isolation of a rabies related virus from the cerebrospinal fluid of a child with 'aseptic meningitis'.

  1972cited by this paper
• An unusual case of human rabies thought to be of chiropteran origin.

  1971cited by this paper
• Laboratory techniques in rabies: the fluorescent antibody test.

  1966cited by this paper

• Antigenic landscape of rabies and related lyssaviruses revealed by cryo-EM

  2026cites this paper
• Genomic and Clinical Analysis of a Fatal Human Lyssavirus irkut Case: Evidence for a Natural Focus in the Russian Far East

  2025cites this paper
• Replicon RNA vaccines: design, delivery, and immunogenicity in infectious diseases and cancer

  2025cites this paper
• Impact of military actions on the epizootic situation with the spread of rabies in animals in Kherson Oblast

  2024cites this paper
• A single dose of recombinant adenoviral vector rabies vaccine expressing two copies of glycoprotein protects mice from lethal virus challenge.

  2024cites this paper
• Probable paralytic rabies in a dog: ante-mortem clinical diagnosis implications in limited resource settings.

  2024cites this paper
• Bat Bites and Rabies PEP in the Croatian Reference Centre for Rabies 1995–2020

  2024cites this paper
• Developing a human monoclonal antibody combination CRM25 to prevent rabies after exposure.

  2024cites this paper
• Establishment of serological neutralizing tests using pseudotyped viruses for comprehensive detection of antibodies against all 18 lyssaviruses

  2023cites this paper
• Regulatory Mechanisms in Biosystems

  2023influential citation
• Sf9 Cell Metabolism Throughout the Recombinant Baculovirus and Rabies Virus-Like Particles Production in Two Culture Systems

  2023cites this paper
• Comparative Neutralization Activity of Commercial Rabies Immunoglobulin against Diverse Lyssaviruses

  2023influential citation
• Lyssavirus P Protein Isoforms Diverge Significantly in Subcellular Interactions Underlying Mechanisms of Interferon Antagonism

  2022cites this paper
• Research progress on neutralizing epitopes and antibodies for the Rabies virus

  2022cites this paper
• Tackling the Threat of Rabies Reintroduction in Europe

  2021cites this paper
• Assessing Rabies Vaccine Protection against a Novel Lyssavirus, Kotalahti Bat Lyssavirus

  2021cites this paper
• Investigating the Interaction between Negative Strand RNA Viruses and Their Hosts for Enhanced Vaccine Development and Production

  2021cites this paper
• Lagos Bat Virus, an Under-Reported Rabies-Related Lyssavirus

  2021cites this paper
• Enhancement of immune responses by co-stimulation of TLR3 - TLR7 agonists as a potential therapeutics against rabies in mouse model.

  2021cites this paper
• Serum Neutralization Profiles of Straw-Colored Fruit Bats (Eidolon helvum) in Makurdi (Nigeria), against Four Lineages of Lagos Bat Lyssavirus

  2021cites this paper
• Structure of the rabies virus glycoprotein trimer bound to a prefusion-specific neutralizing antibody

  2021cites this paper
• Spillover of West Caucasian Bat Lyssavirus (WCBV) in a Domestic Cat and Westward Expansion in the Palearctic Region

  2021cites this paper
• Incursion of European Bat Lyssavirus 1 (EBLV-1) in Serotine Bats in the United Kingdom

  2021cites this paper
• An inter-laboratory trial as a tool to increase rabies diagnostic capabilities of Sub-Saharan African Veterinary laboratories

  2020cites this paper
• Between roost contact is essential for maintenance of European bat lyssavirus type-2 in Myotis daubentonii bat reservoir: ‘The Swarming Hypothesis’

  2020cites this paper
• Next generation of rabies vaccines

  2020cites this paper
• Bat rabies

  2020cites this paper
• Epidemiology

  2020cites this paper
• Structural comparison of the C-terminal domain of functionally divergent lyssavirus P proteins.

  2020cites this paper
• Lyssavirus Vaccine with a Chimeric Glycoprotein Protects across Phylogroups

  2020influential citation
• History of Rabies and Rabies Vaccines

  2020cites this paper
• Rabies Life Cycle, Transmission and Pathogenesis

  2020cites this paper
• Rabies and Rabies Vaccines

  2020cites this paper
• New Rabies Vaccines for Use in Humans

  2019cites this paper
• Current Rabies Vaccines Do Not Confer Protective Immunity against Divergent Lyssaviruses Circulating in Europe

  2019cites this paper
• Bats and Viruses: Emergence of Novel Lyssaviruses and Association of Bats with Viral Zoonoses in the EU

  2019cites this paper
• Isolation, antigenicity and immunogenicity of Lleida bat lyssavirus.

  2018cites this paper
• Antigenic site changes in the rabies virus glycoprotein dictates functionality and neutralizing capability against divergent lyssaviruses.

  2018cites this paper
• The spread and evolution of rabies virus: conquering new frontiers

  2018cites this paper
• Kuduz Enfeksiyonunun Moleküler Evrimi, Çeşitliliği ve Coğrafik Dağılımı

  2018cites this paper
• The impact of novel lyssavirus discovery

  2017cites this paper
• Passive surveillance of United Kingdom bats for lyssaviruses (2005–2015)

  2017cites this paper
• The Recently Discovered Bokeloh Bat Lyssavirus: Insights Into Its Genetic Heterogeneity and Spatial Distribution in Europe and the Population Genetics of Its Primary Host.

  2017cites this paper
• Genetic analysis of a rabies virus host shift event reveals within-host viral dynamics in a new host

  2017cites this paper
• Protection of bats (Eptesicus fuscus) against rabies following topical or oronasal exposure to a recombinant raccoon poxvirus vaccine

  2017cites this paper
• Barriers to innovation in human rabies prophylaxis and treatment: A causal analysis of insights from key opinion leaders and literature

  2017cites this paper
• Generation of Arctic-like Rabies Viruses Containing Chimeric Glycoproteins Enables Serological Potency Studies

  2017influential citation
• Natural exposure of bats in Grenada to rabies virus

  2017cites this paper
• Lagos Bat Virus Infection Dynamics in Free-Ranging Straw-Colored Fruit Bats (Eidolon helvum)

  2017cites this paper
• European bat lyssavirus type 2 in Finland : Surveillance, evolutionary analysis, and prevention with vaccination

  2017cites this paper
• Vertical Transmission 2

  2017cites this paper
• Current Status and Development of Vaccines and Other Biologics for Human Rabies Prevention

  2016cites this paper
• A novel rabies virus lipopeptide provides a better protection by improving the magnitude of DCs activation and T cell responses.

  2016cites this paper
• Characterization of epitopes on the rabies virus glycoprotein by selection and analysis of escape mutants.

  2016cites this paper
• Quantification of Lyssavirus-Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudotype Particles

  2016cites this paper
• Rabies Control and Treatment: From Prophylaxis to Strategies with Curative Potential

  2016cites this paper
• Rabies: Virus and Disease

  2015cites this paper
• La rage animale : risques autochtones et d’importation, mesures à prendre

  2015cites this paper
• Self-amplifying mRNA vaccines.

  2015cites this paper
• Reverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeutics.

  2015cites this paper
• Defining an emerging disease.

  2015cites this paper
• Elimination of Rabies : A Missed Opportunity

  2015cites this paper
• Investigating the antigenicity of the lyssavirus glycoprotein

  2015cites this paper
• Role of the glycoprotein G in lyssavirus pathogenicity

  2015cites this paper
• Why we can prevent, control and possibly treat – but will not eradicate – rabies

  2015cites this paper
• Rabies in Europe: what are the risks?

  2014cites this paper
• Comparison of safety and immunogenicity of purified chick embryo cell vaccine using Zagreb and Essen regimens in patients with category II exposure in China

  2014cites this paper
• Australian bat lyssavirus: implications for public health

  2014cites this paper
• Analysis of Adaptive Evolution in Lyssavirus Genomes Reveals Pervasive Diversifying Selection during Species Diversification

  2014cites this paper
• Interaction of rabies virus P-protein with STAT proteins is critical to lethal rabies disease.

  2014cites this paper
• Antigenic and genetic characterisation of a divergent African virus, Ikoma lyssavirus SHORT TITLE Characterisation of Ikoma lyssavirus AUTHORS:

  2014cites this paper
• Antigenic and genetic characterization of a divergent African virus, Ikoma lyssavirus

  2014influential citation
• Current status of rabies and prospects for elimination

  2014cites this paper
• Jet set pets: examining the zoonosis risk in animal import and travel across the European Union

  2014cites this paper
• Chicken Interferon-Inducible Transmembrane Protein 3 Restricts Influenza Viruses and Lyssaviruses In Vitro

  2013cites this paper
• In Vitro Influenza Viruses and Lyssaviruses Transmembrane Protein 3 Restricts Chicken Interferon-Inducible

  2013cites this paper
• Interaction of Virus P-Protein with STAT Proteins is Critical to Lethal Rabies Disease.

  2013cites this paper